Skip to main content
Top
Published in: Inflammation 4/2012

01-08-2012

Quercetin Inhibits IL-1β-Induced Proliferation and Production of MMPs, COX-2, and PGE2 by Rheumatoid Synovial Fibroblast

Authors: Myung-Soon Sung, Eun-Gyeong Lee, Hyun-Soon Jeon, Han-Jung Chae, Seoung Ju Park, Yong Chul Lee, Wan-Hee Yoo

Published in: Inflammation | Issue 4/2012

Login to get access

Abstract

This study was aimed to determine the effects of quercetin on the interleukin-1β (IL-1β)-induced proliferation of rheumatoid synovial fibroblasts (RASFs) and production of matrix metalloproteinases (MMPs), cyclooxygenase (COX), and prostaglandin E2 (PGE2) by RASFs. The proliferation and apoptosis of RASFs was evaluated with CCK-8 reagent and flow cytometry in the presence of IL-1with CCK-8 reagquercetin. The expression of MMPs, IL-1β enhanced the expression of MMP-1, MMP-3, tissue inhibitor of metalloproteinase (TIMP)-1, COXs, PGE2, and intracellular mitogen-activated protein kinase (MAPK) signalings including phosphorylated extracellular signal-regulated kinase (p-ERK), p-p38, phosphorylated c-Jun N-terminal kinase (p-JNK), and nuclear factor kB (NF-kB) were examined by immunoblotting or semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) in conditions as described above. Quercetin inhibits unstimulated and IL-1β-induced proliferation of RASFs and MMP-1, 3, COX-2 messenger ribonucleic acid and protein expression, PGE2 production induced with IL-1β. Quercetin also inhibits the phosphorylation of ERK-1/2, p38, JNK and activation of NF-kB by IL-1ed. These results indicate that quercetin inhibits synovial fibroblasts proliferation and MMPs, COX-2, and PGE2 production, which involved joint destruction in rheumatoid arthritis (RA), and suggest that it might be a new therapeutic agent for management of RA.
Literature
1.
go back to reference Cawston, T.E. 1995. Proteinase and connective tissue breakdown. In Mechanisms and models in rheumatoid arthritis, ed. B. Henderson, J.C.W. Edwards, and E.R. Pettipher. London: Academic Press. Cawston, T.E. 1995. Proteinase and connective tissue breakdown. In Mechanisms and models in rheumatoid arthritis, ed. B. Henderson, J.C.W. Edwards, and E.R. Pettipher. London: Academic Press.
2.
go back to reference Han, M.K., J.S. Kim, B.H. Park, et al. 2003. NF-kappaB-dependent lymphocyte hyperadhesiveness to synovial fibroblasts by hypoxia and reoxygenation: Potential role in rheumatoid arthritis. Journal of Leukocyte Biology 73: 525–529.PubMedCrossRef Han, M.K., J.S. Kim, B.H. Park, et al. 2003. NF-kappaB-dependent lymphocyte hyperadhesiveness to synovial fibroblasts by hypoxia and reoxygenation: Potential role in rheumatoid arthritis. Journal of Leukocyte Biology 73: 525–529.PubMedCrossRef
3.
go back to reference Firestein, G.S. 1997. Etiology and pathogenesis of rheumatoid arthritis. In Textbook of rheumatology, 5th ed, ed. W.N. Kelley, E.D. Harris Jr., S. Ruddy, and C.B. Sledge, 851–897. Philadelphia: WB Saunders. Firestein, G.S. 1997. Etiology and pathogenesis of rheumatoid arthritis. In Textbook of rheumatology, 5th ed, ed. W.N. Kelley, E.D. Harris Jr., S. Ruddy, and C.B. Sledge, 851–897. Philadelphia: WB Saunders.
4.
go back to reference Choy, E.H., and G.S. Panayi. 2001. Cytokine pathways and joint inflammation in rheumatoid arthritis. The New England Journal of Medicine 344: 907–916.PubMedCrossRef Choy, E.H., and G.S. Panayi. 2001. Cytokine pathways and joint inflammation in rheumatoid arthritis. The New England Journal of Medicine 344: 907–916.PubMedCrossRef
5.
go back to reference Cho, E.J., T. Yokozawa, D.Y. Rhyu, H.Y. Kim, N. Shibahara, and J.C. Park. 2003. The inhibitory effects of 12 medicinal plants and their component compounds on lipid peroxidation. The American Journal of Chinese Medicine 31: 907–917.PubMedCrossRef Cho, E.J., T. Yokozawa, D.Y. Rhyu, H.Y. Kim, N. Shibahara, and J.C. Park. 2003. The inhibitory effects of 12 medicinal plants and their component compounds on lipid peroxidation. The American Journal of Chinese Medicine 31: 907–917.PubMedCrossRef
6.
go back to reference Kang, D.G., T.Y. Hur, G.M. Lee, H. Oh, T.O. Kwon, E.J. Sohn, and H.S. Lee. 2002. Effects of Cudrania tricuspidata water extract on blood pressure and renal functions in NO-dependent hypertension. Life Sciences 70: 2599–2609.PubMedCrossRef Kang, D.G., T.Y. Hur, G.M. Lee, H. Oh, T.O. Kwon, E.J. Sohn, and H.S. Lee. 2002. Effects of Cudrania tricuspidata water extract on blood pressure and renal functions in NO-dependent hypertension. Life Sciences 70: 2599–2609.PubMedCrossRef
7.
go back to reference Chang, S.H., E.J. Jung, D.G. Lim, B. Oyungerel, K.I. Lim, E. Her, W.S. Choi, M.H. Jun, K.D. Choi, D.J. Han, and S.C. Kim. 2008. Anti-inflammatory action of Cudrania tricuspidata on spleen cell and T lymphocyte proliferation. Journal of Pharmacy and Pharmacology 60: 1221–1226.PubMedCrossRef Chang, S.H., E.J. Jung, D.G. Lim, B. Oyungerel, K.I. Lim, E. Her, W.S. Choi, M.H. Jun, K.D. Choi, D.J. Han, and S.C. Kim. 2008. Anti-inflammatory action of Cudrania tricuspidata on spleen cell and T lymphocyte proliferation. Journal of Pharmacy and Pharmacology 60: 1221–1226.PubMedCrossRef
8.
go back to reference Seo, W.G., H.O. Pae, G.S. Oh, K.Y. Chai, Y.G. Yun, H.T. Chung, K.K. Jang, and T.O. Kwon. 2001. Ethyl acetate extract of the stem bark of Cudrania tricuspidata induces apoptosis in human leukemia HL-60 cells. The American Journal of Chinese Medicine 29: 313–320.PubMedCrossRef Seo, W.G., H.O. Pae, G.S. Oh, K.Y. Chai, Y.G. Yun, H.T. Chung, K.K. Jang, and T.O. Kwon. 2001. Ethyl acetate extract of the stem bark of Cudrania tricuspidata induces apoptosis in human leukemia HL-60 cells. The American Journal of Chinese Medicine 29: 313–320.PubMedCrossRef
9.
go back to reference Lee, E.G., S.L. Lee, H.J. Chae, S.J. Park, Y.C. Lee, and W.H. Yoo. 2010. Ethyl acetate fraction from Cudrania tricuspidata inhibits IL-1β-induced rheumatoid synovial fibroblast proliferation and MMPs, COX-2 and PGE2 production. Biological Research 43: 225–231.PubMedCrossRef Lee, E.G., S.L. Lee, H.J. Chae, S.J. Park, Y.C. Lee, and W.H. Yoo. 2010. Ethyl acetate fraction from Cudrania tricuspidata inhibits IL-1β-induced rheumatoid synovial fibroblast proliferation and MMPs, COX-2 and PGE2 production. Biological Research 43: 225–231.PubMedCrossRef
10.
go back to reference Guardia, T., A.E. Rotelli, A.O. Juarez, and L.E. Pelzer. 2001. Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Farmaco 56: 683–687.PubMedCrossRef Guardia, T., A.E. Rotelli, A.O. Juarez, and L.E. Pelzer. 2001. Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Farmaco 56: 683–687.PubMedCrossRef
11.
go back to reference Jackson, J.K., T. Higo, W.L. Hunter, and H.M. Burt. 2006. The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis. Inflammation Research 55: 168–175.PubMedCrossRef Jackson, J.K., T. Higo, W.L. Hunter, and H.M. Burt. 2006. The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis. Inflammation Research 55: 168–175.PubMedCrossRef
12.
go back to reference Comalada, M., D. Camuesco, S. Sierra, I. Ballester, J. Xaus, J. Gálvez, and A. Zarzuelo. 2006. In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway. European Journal of Immunology 35: 584–592.CrossRef Comalada, M., D. Camuesco, S. Sierra, I. Ballester, J. Xaus, J. Gálvez, and A. Zarzuelo. 2006. In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway. European Journal of Immunology 35: 584–592.CrossRef
13.
go back to reference Kumazawa, Y., K. Kawaguchi, and H. Takimoto. 2006. Immunomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor alpha. Current Pharmaceutical Design 12: 4271–4279.PubMedCrossRef Kumazawa, Y., K. Kawaguchi, and H. Takimoto. 2006. Immunomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor alpha. Current Pharmaceutical Design 12: 4271–4279.PubMedCrossRef
14.
go back to reference Mamani-Matsuda, M., T. Kauss, A. Al-Kharrat, J. Rambert, F. Fawaz, D. Thiolat, D. Moynet, S. Coves, D. Malvy, and M.D. Mossalayi. 2006. Therapeutic and preventive properties of quercetin in experimental arthritis correlate with decreased macrophage inflammatory mediators. Biochemical Pharmacology 72: 1304–1310.PubMedCrossRef Mamani-Matsuda, M., T. Kauss, A. Al-Kharrat, J. Rambert, F. Fawaz, D. Thiolat, D. Moynet, S. Coves, D. Malvy, and M.D. Mossalayi. 2006. Therapeutic and preventive properties of quercetin in experimental arthritis correlate with decreased macrophage inflammatory mediators. Biochemical Pharmacology 72: 1304–1310.PubMedCrossRef
15.
go back to reference Ruiz, P.A., A. Braune, G. Holzlwimmer, L. Quintanilla-Fend, and D. Haller. 2007. Quercetin inhibits TNF-induced NF-kappaB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells. Journal of Nutrition 137: 1208–1215.PubMed Ruiz, P.A., A. Braune, G. Holzlwimmer, L. Quintanilla-Fend, and D. Haller. 2007. Quercetin inhibits TNF-induced NF-kappaB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells. Journal of Nutrition 137: 1208–1215.PubMed
16.
go back to reference Arnett, F.C., S.M. Edworthy, D.A. Bloch, D.J. McShane, J.F. Fries, N.S. Cooper, L.A. Healey, S.R. Kaplan, M.H. Liang, and H.S. Luthra. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 31: 315–324.PubMedCrossRef Arnett, F.C., S.M. Edworthy, D.A. Bloch, D.J. McShane, J.F. Fries, N.S. Cooper, L.A. Healey, S.R. Kaplan, M.H. Liang, and H.S. Luthra. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 31: 315–324.PubMedCrossRef
17.
go back to reference Lee, H.Y., H.S. Jeon, E.K. Song, M.K. Han, S.I. Park, S.I. Lee, H.J. Yun, J.R. Kim, J.S. Kim, Y.C. Lee, S.I. Kim, H.R. Kim, J.Y. Choi, I. Kang, H.Y. Kim, and W.H. Yoo. 2006. CD40 ligation of rheumatoid synovial fibroblasts regulates RANKL-mediated osteoclastogenesis: evidence of NF-kappaB-dependent, CD40-mediated bone destruction in rheumatoid arthritis. Arthritis and Rheumatism 54: 1747–1758.PubMedCrossRef Lee, H.Y., H.S. Jeon, E.K. Song, M.K. Han, S.I. Park, S.I. Lee, H.J. Yun, J.R. Kim, J.S. Kim, Y.C. Lee, S.I. Kim, H.R. Kim, J.Y. Choi, I. Kang, H.Y. Kim, and W.H. Yoo. 2006. CD40 ligation of rheumatoid synovial fibroblasts regulates RANKL-mediated osteoclastogenesis: evidence of NF-kappaB-dependent, CD40-mediated bone destruction in rheumatoid arthritis. Arthritis and Rheumatism 54: 1747–1758.PubMedCrossRef
18.
go back to reference Hodgkin, P.D., L.C. Yamashita, R.L. Coffman, and M.R. Kehry. 1990. Separation of events mediating B cell proliferation and Ig production by using T cell membranes and lymphokines. Journal of Immunology 145: 2025–2034. Hodgkin, P.D., L.C. Yamashita, R.L. Coffman, and M.R. Kehry. 1990. Separation of events mediating B cell proliferation and Ig production by using T cell membranes and lymphokines. Journal of Immunology 145: 2025–2034.
19.
go back to reference Guan, Y., Z. Yin, L. Guo, X. Huang, W. Ye, and W. Shen. 2009. Studies on chemical constituents from stems of Cudrania tricuspidata. Zhongguo Zhongyao Zazhi 34: 1108–1110.PubMed Guan, Y., Z. Yin, L. Guo, X. Huang, W. Ye, and W. Shen. 2009. Studies on chemical constituents from stems of Cudrania tricuspidata. Zhongguo Zhongyao Zazhi 34: 1108–1110.PubMed
20.
go back to reference Yu, E.S., H.J. Min, S.Y. An, H.Y. Won, J.H. Hong, and E.S. Hwang. 2008. Regulatory mechanisms of IL-2 and IFNgamma suppression by quercetin in T helper cells. Biochemical Pharmacology 76: 70–78.PubMedCrossRef Yu, E.S., H.J. Min, S.Y. An, H.Y. Won, J.H. Hong, and E.S. Hwang. 2008. Regulatory mechanisms of IL-2 and IFNgamma suppression by quercetin in T helper cells. Biochemical Pharmacology 76: 70–78.PubMedCrossRef
21.
go back to reference Gitter, B.D., J.M. Labus, S.L. Lees, and M.E. Scheetz. 1989. Characteristics of human synovial fibroblast activation by IL-1 beta and TNF alpha. Immunology 66: 196–200.PubMed Gitter, B.D., J.M. Labus, S.L. Lees, and M.E. Scheetz. 1989. Characteristics of human synovial fibroblast activation by IL-1 beta and TNF alpha. Immunology 66: 196–200.PubMed
22.
go back to reference Crofford, L.J., R.L. Wilder, A.P. Ristimaki, H. Sano, E.F. Remmers, H.R. Epps, and T. Hla. 1994. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids. Journal of Clinical Investigation 93: 1095–1101.PubMedCrossRef Crofford, L.J., R.L. Wilder, A.P. Ristimaki, H. Sano, E.F. Remmers, H.R. Epps, and T. Hla. 1994. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids. Journal of Clinical Investigation 93: 1095–1101.PubMedCrossRef
23.
go back to reference Tolboom, T.C., E. Pieterman, W.H. van der Laan, R.E. Toes, A.L. Huidekoper, R.G. Nelissen, F.C. Breedveld, and T.W. Huizinga. 2002. Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10. Annals of the Rheumatic Diseases 61: 975–980.PubMedCrossRef Tolboom, T.C., E. Pieterman, W.H. van der Laan, R.E. Toes, A.L. Huidekoper, R.G. Nelissen, F.C. Breedveld, and T.W. Huizinga. 2002. Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10. Annals of the Rheumatic Diseases 61: 975–980.PubMedCrossRef
24.
go back to reference Martel-Pelletier, J., J.P. Pelletier, and H. Fahmi. 2004. New insights into prostaglandin biology. Journal of Rheumatology 31: 14–16.PubMed Martel-Pelletier, J., J.P. Pelletier, and H. Fahmi. 2004. New insights into prostaglandin biology. Journal of Rheumatology 31: 14–16.PubMed
25.
go back to reference Verma, I.M., J.K. Stevenson, E.M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes & Development 9: 2723–2735.CrossRef Verma, I.M., J.K. Stevenson, E.M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes & Development 9: 2723–2735.CrossRef
26.
go back to reference Han, Z., D.L. Boyle, L. Chang, B. Bennett, M. Karin, L. Yang, A.M. Manning, and G.S. Firestein. 2001. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. Journal of Clinical Investigation 108: 73–81.PubMed Han, Z., D.L. Boyle, L. Chang, B. Bennett, M. Karin, L. Yang, A.M. Manning, and G.S. Firestein. 2001. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. Journal of Clinical Investigation 108: 73–81.PubMed
27.
go back to reference Guan, Z., L.D. Baier, and A.R. Morrison. 1997. p38 mitogen-activated protein kinase downregulates nitric oxide and up-regulates prostaglandin E2 biosynthesis stimulated by interleukin-1beta. Journal of Biological Chemistry 272: 8083–8089.PubMedCrossRef Guan, Z., L.D. Baier, and A.R. Morrison. 1997. p38 mitogen-activated protein kinase downregulates nitric oxide and up-regulates prostaglandin E2 biosynthesis stimulated by interleukin-1beta. Journal of Biological Chemistry 272: 8083–8089.PubMedCrossRef
28.
go back to reference Lasa, M., M. Brook, J. Saklatvala, and A.R. Clark. 2001. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Molecular and Cellular Biology 21: 771–780.PubMedCrossRef Lasa, M., M. Brook, J. Saklatvala, and A.R. Clark. 2001. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Molecular and Cellular Biology 21: 771–780.PubMedCrossRef
29.
go back to reference McIntyre, K.W., D.J. Shuster, K.M. Gillooly, D.M. Dambach, M.A. Pattoli, P. Lu, X.D. Zhou, Y. Qiu, F.C. Zusi, and J.R. Burke. 2003. A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice. Arthritis and Rheumatism 48: 2652–2659.PubMedCrossRef McIntyre, K.W., D.J. Shuster, K.M. Gillooly, D.M. Dambach, M.A. Pattoli, P. Lu, X.D. Zhou, Y. Qiu, F.C. Zusi, and J.R. Burke. 2003. A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice. Arthritis and Rheumatism 48: 2652–2659.PubMedCrossRef
30.
go back to reference Nishikawa, M., A. Myoui, T. Tomita, K. Takahi, A. Nampei, and H. Yoshikawa. 2003. Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653. Arthritis and Rheumatism 48: 2670–2681.PubMedCrossRef Nishikawa, M., A. Myoui, T. Tomita, K. Takahi, A. Nampei, and H. Yoshikawa. 2003. Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653. Arthritis and Rheumatism 48: 2670–2681.PubMedCrossRef
31.
go back to reference Min, Y.D., C.H. Choi, H. Bark, H.Y. Son, H.H. Park, S. Lee, J.W. Park, E.K. Park, H.I. Shin, and S.H. Kim. 2007. Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kappaB and p38 MAPK in HMC-1 human mast cell line. Inflammation Research 56: 210–215.PubMedCrossRef Min, Y.D., C.H. Choi, H. Bark, H.Y. Son, H.H. Park, S. Lee, J.W. Park, E.K. Park, H.I. Shin, and S.H. Kim. 2007. Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kappaB and p38 MAPK in HMC-1 human mast cell line. Inflammation Research 56: 210–215.PubMedCrossRef
32.
go back to reference Sato, M., T. Miyazaki, F. Kambe, K. Maeda, and H. Seo. 1997. Quercetin, a bioflavonoid, inhibits the induction of interleukin 8 and monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha in cultured human synovial cells. Journal of Rheumatology 24: 1680–1684.PubMed Sato, M., T. Miyazaki, F. Kambe, K. Maeda, and H. Seo. 1997. Quercetin, a bioflavonoid, inhibits the induction of interleukin 8 and monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha in cultured human synovial cells. Journal of Rheumatology 24: 1680–1684.PubMed
Metadata
Title
Quercetin Inhibits IL-1β-Induced Proliferation and Production of MMPs, COX-2, and PGE2 by Rheumatoid Synovial Fibroblast
Authors
Myung-Soon Sung
Eun-Gyeong Lee
Hyun-Soon Jeon
Han-Jung Chae
Seoung Ju Park
Yong Chul Lee
Wan-Hee Yoo
Publication date
01-08-2012
Publisher
Springer US
Published in
Inflammation / Issue 4/2012
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-012-9473-2

Other articles of this Issue 4/2012

Inflammation 4/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.